EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of modulator therapy on the Pseudomonas aeruginosa cystic fibrosis lung transcriptome

Morgana Letizia iD, Lauren E Whiteley, Frances L Diggle, Angela N Davis iD, Sarah J Morgan, Brenda Grogan, John Baugh, Edward F McKone, Pradeep K Singh, Marvin Whiteley iD

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2622466123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Morgana Letizia und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences and Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, GA 30332. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Cystic Fibrosis, Pseudomonas Infections, Transcriptome. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation (CFF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic lung infection with Pseudomonas aeruginosa is a major complication of cystic fibrosis (CF), contributing to lung function decline and increased morbidity and mortality. Laboratory models are used to study CF infections, but their relevance depends on how accurately they reproduce microbial physiology during human infection. We previously developed a framework that uses bacterial gene expression in human infections to quantify model accuracy. Here, we applied this framework to determine how a major therapeutic intervention impacts P. aeruginosa physiology in the lungs of people with CF (pwCF) and to develop and evaluate refined preclinical models. We focused on elexacaftor/tezacaftor/ivacaftor (ETI), a highly effective CFTR modulator therapy that has improved outcomes for pwCF. However, evidence indicates that P. aeruginosa lung infections persist despite ETI therapy. Analysis of P. aeruginosa transcriptomes from human sputum collected before and after ETI initiation revealed minimal changes in gene expression, indicating that the CF airway continues to support a similar bacterial transcriptional state despite therapy. We then evaluated how strain selection, zinc limitation, and polymicrobial coculture influence the ability of laboratory models to recapitulate P. aeruginosa gene expression in human CF sputum. Growth of CF clinical isolates in zinc-limited synthetic CF sputum medium produced the most accurate model, whereas population-based cultures and coculture with Staphylococcus aureus had limited effects. These findings show that ETI therapy has little impact on the conserved P. aeruginosa transcriptional state in human CF sputum and that refined sputum-like models remain useful for studying persistent infection in the postmodulator era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaCystic FibrosisPseudomonas InfectionsTranscriptomeLungHumansQuinolonesIndolesSputumAminophenolsGene Expression Regulation, BacterialCystic Fibrosis Transmembrane Conductance RegulatorBenzodioxolesPyrroles

Stichwörter der Autor:innen

CF modulatorsPseudomonas aeruginosacystic fibrosismodel systemtranscriptomics

Substanzen

QuinolonesIndolesAminophenolstezacaftorCystic Fibrosis Transmembrane Conductance RegulatorivacaftorBenzodioxolesPyrroles

Autor:innen und Institutionen

  • School of Biological Sciences and Center for Microbial Dynamics and Infection, Georgia Institute of Technology, Atlanta, GA 30332.
  • Emory-Children's Cystic Fibrosis Center, Atlanta, GA 30322.
  • Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.
  • Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195.
  • National Referral Center for Adult Cystic Fibrosis, National Referral Center for Adult Cystic Fibrosis, St. Vincent's University Hospital, Dublin D04 T6F4, Ireland.
  • University College Dublin School of Medicine, Dublin D04 C7X2, Ireland.

ORCID-Profile: Morgana Letizia, Angela N Davis, Marvin Whiteley

Förderung

  • Cystic Fibrosis Foundation (CFF)

Zitieren

APA

Letizia, M., Whiteley, L. E., Diggle, F. L., Davis, A. N., Morgan, S. J., Grogan, B., Baugh, J., McKone, E. F., Singh, P. K., & Whiteley, M. (2026). The impact of modulator therapy on the Pseudomonas aeruginosa cystic fibrosis lung transcriptome. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2622466123

Vancouver

Letizia M, Whiteley LE, Diggle FL, Davis AN, Morgan SJ, Grogan B, et al. The impact of modulator therapy on the Pseudomonas aeruginosa cystic fibrosis lung transcriptome. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2622466123

BibTeX
@article{Letizia2026,
  author = {Letizia, Morgana and Whiteley, Lauren E and Diggle, Frances L and Davis, Angela N and Morgan, Sarah J and Grogan, Brenda and Baugh, John and McKone, Edward F and Singh, Pradeep K and Whiteley, Marvin},
  title = {The impact of modulator therapy on the Pseudomonas aeruginosa cystic fibrosis lung transcriptome},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2622466123}
}
Kostenlos starten →